Halo Pharma becomes a standalone drug product CDMO after the sale of Noramco’s API assets, adding sterile services by H2 2026 ...
Repertoire Immune Medicines partners with Eli Lilly to develop tolerizing therapies for autoimmune diseases, receiving $85 ...
With a potential US government shutdown looming, Megha Sinha, Kamet Consulting, says to treat FDA disruptions as predictable ...
Government shutdowns lead to decreased predictability, causing delays in new submissions and manufacturing changes. Key risk ...
Rare disease clinical trials are smaller and often use surrogate endpoints, reducing costs but posing unique operational ...
He helps companies lay the foundation for successful launches through data-backed strategies spanning indication assessment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results